Document:

Exhibit

Exhibit 10.1
Viacom Inc.
2016 Long-Term Management Incentive Plan

2019 Terms and Conditions to the Performance Share Units Certificate
ARTICLE I
TERMS OF PERFORMANCE SHARE UNITS
Section 1.1    Grant of Performance Share Units.  The Performance Share Units (the “Performance Share Units” or “PSUs”) awarded to a Participant are subject to (i) the Performance Share Units Certificate (the “Certificate”), (ii) the terms and conditions contained herein and (iii) the 2016 Long-Term Management Incentive Plan (the “Plan”), the provisions of which are hereby incorporated by reference.  A copy of the Plan and the Prospectus dated November 30, 2018 are being provided simultaneously on-line or attached hereto.  Capitalized terms that are not otherwise defined herein have the meanings assigned to them in the Certificate or the Plan.  Performance Share Units are notional units of measurement and represent the right to receive a number of shares of Class B Common Stock depending on the Company’s performance against specific pre-determined goals.  The number of PSUs issued to a Participant will be determined as follows: (a) twenty-five percent (25%) of the value of the award set forth in the Certificate will be issued in PSUs subject to the TSR performance of the Class B Common Stock in comparison to the TSR performance of the common stock of companies comprising the Reference Group, with the target number of PSUs subject to TSR performance determined by dividing such portion of the value by the Date of Grant fair value determined by FAS 123 Solutions using a Monte Carlo valuation model (“Target TSR Shares”), and (b) seventy-five percent (75%) of the value of the award set forth in the Certificate will be issued in PSUs subject to the Company’s Adjusted Diluted EPS from Continuing Operations against target, with the target number of PSUs subject to such Adjusted Diluted EPS from Continuing Operations performance determined by dividing such portion of the value by the closing price of a share of Class B Common Stock on the Date of Grant (“Target EPS Shares”), each as set forth in the Certificate.
Section 1.2    Terms of Performance Share Units.  
(a)    Valuation.  
(1)    TSR Shares. As of the Determination Date, the TSR of the Class B Common Stock over the relevant Measurement Period will be measured against the TSR of the common stock of the companies comprising the Reference Group over the relevant Measurement Period.  The percentile ranking of the TSR of the Class B Common Stock as compared to the TSR of the common stock of the companies comprising the Reference Group will be used to calculate the number of shares of Class B Common Stock that the Participant will receive pursuant to this Section 1.2(a)(1), in accordance with the following schedule:
	
	
	Schedule

	•   If the Company achieves less than the 25th percentile TSR, the Target TSR Shares will be forfeited pursuant to this Section 1.2(a)(1)

1

	
	
	•   If the Company achieves the 25th percentile TSR, a number of shares of Class B Common Stock equal to 25% of the target number of Target TSR Shares will be delivered pursuant to this Section 1.2(a)(1)

	•   If the Company achieves the 50th percentile TSR, a number of shares of Class B Common Stock equal to 100% of the Target TSR Shares will be delivered pursuant to this Section 1.2(a)(1)

	•   If the Company achieves the 100th percentile TSR (that is, if it is the first ranked company in the Reference Group for TSR), a number of shares of Class B Common Stock equal to 200% of the Target TSR Shares will be delivered pursuant to this Section 1.2(a)(1)

For Company achievement at an intermediate point between the 25th and 50th percentile, or between the 50th percentile and the 100th percentile, the percentage of the Target TSR Shares to be delivered will be interpolated between the respective percentages at such percentiles.  For example, if the Company were to achieve the 70th percentile TSR, 140% of the Target TSR Shares would be delivered pursuant to this Section 1.2(a)(1).
(2)    EPS Shares.  As of the Determination Date, the Adjusted Diluted EPS from Continuing Operations for the FY19 Period will be measured against the Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period, which will be used to calculate the number of shares of Class B Common Stock that the Participant will receive pursuant to this Section 1.2(a)(2), in accordance with the following schedule:
	
	
	Schedule

	•        If the Adjusted Diluted EPS from Continuing Operations for the FY19 Period is less than 80% of the Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period, 100% of the Target EPS Shares will be forfeited pursuant to this Section 1.2(a)(2)

	•        If the Adjusted Diluted EPS from Continuing Operations for the FY19 Period is 80% of the Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period, a number of shares of Class B Common Stock equal to 50% of the Target EPS Shares will be delivered under the award pursuant to this Section 1.2(a)(2)

	•        If the Adjusted Diluted EPS from Continuing Operations for the FY19 Period is 100% of the Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period, a number of shares of Class B Common Stock equal to 100% of the Target  EPS Shares will be delivered under the award pursuant to this Section 1.2(a)(2)

	•        If the Adjusted Diluted EPS from Continuing Operations for the FY19 Period is 120% or more of the Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period, a number of shares of Class B Common Stock equal to 200% of the target number of EPS Shares will be delivered under the award pursuant to this Section 1.2(a)(2)

For Company achievement at an intermediate point between 80% and 100% of the Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period, or between 100% and 120% of the Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period, the percentage of the Target EPS Shares to be delivered pursuant to this Section 1.2(a)(2) will be interpolated 

2

between the respective percentages  at such percentiles.  For example, if the Company were to achieve 90% of the Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period, a number of shares of Class B Common Stock equal to 75% of the Target EPS Shares would be delivered under the award pursuant to this Section 1.2(a)(2).
(b)    Settlement and Delivery of Shares.  Shares delivered in settlement of the Performance Share Units will be delivered, net of any shares withheld for Taxes pursuant to Section 4.3, no later than four (4) weeks following the Determination Date; provided, however, in the event that the Participant would be subject to federal income tax on the shares of Class B Common Stock payable under the valuation criteria under Section 1.2(a)(2) before the Determination Date, then to the extent permissible under Section 409A, such shares of Class B Common Stock, net of any Shares withheld for Taxes pursuant to Section 4.3, and as adjusted pursuant to Section 1.2(d) if applicable, shall be delivered in settlement of that portion of the Performance Share Units no later than four (4) weeks following the date on which the Participant became subject to federal income tax on the shares of Class B Common Stock payable under the valuation criteria under  Section 1.2(a)(2). 
(c)    Transfer Restriction on Delivered Shares.   Shares delivered in settlement of the Performance Share Units, net of any shares withheld for Taxes pursuant to Section 4.3, shall not be transferable by the Participant, except by will, the laws of descent and distribution or beneficiary designation for a 6-month period beginning on the Determination Date; provided that the Committee may permit other transferability, subject to any conditions and limitations that it may, in its sole discretion, impose.
(d)    Termination of Employment.
(1)    In the event the Participant’s employment with the Company or a Subsidiary terminates in a Qualifying Termination prior to September 30, 2021, the number of shares of Class B Common Stock that the Participant will receive for the applicable Measurement Period will be determined by multiplying the shares of Class B Common Stock determined under the valuation criteria under Section 1.2(a) as of the Determination Date by a fraction, the numerator of which is the number of days starting with and inclusive of October 1, 2018 and ending on the last day of the Measurement Period and the denominator of which is the number of days starting with and inclusive of October 1, 2018 and ending on the Determination Date. 
(2)    In the event the Participant’s employment with the Company or a Subsidiary terminates for any reason other than a Qualifying Termination, the Participant shall forfeit all unvested Performance Share Units as of the date of such event.

ARTICLE II
EFFECT OF CERTAIN CORPORATE CHANGES
In the event of a merger, consolidation, stock split, reverse stock split, dividend, distribution, combination, reclassification, reorganization, split-up, spin-off or recapitalization that changes the character or amount of the Class B Common Stock or any other changes in the 

3

corporate structure, equity securities or capital structure of the Company, the Committee shall make such adjustments, if any, to the number and kind of securities subject to the Performance Share Units, as it deems appropriate. The Committee may, in its sole discretion, also make such other adjustments as it deems appropriate in order to preserve the benefits or potential benefits intended to be made available hereunder.  Such determinations by the Committee shall be conclusive and binding on all persons for all purposes.  

ARTICLE III
DEFINITIONS
As used herein, the following terms shall have the following meanings:  
(a)    “Adjusted Diluted EPS from Continuing Operations” for a given fiscal year means the adjusted diluted EPS from continuing operations, as reportable by the Company on Form 10-K, subject to adjustment by the Committee for any recapitalization,  reorganization,  merger,  acquisition,  divestiture, consolidation,  spin-off,  combination,  liquidation,  dissolution,  sale  of assets,  or  other  similar  corporate  transaction  or  event  or  any  other extraordinary event occurs, or any other event or circumstance occurs which has the effect, as determined by the Committee, of distorting the applicable diluted EPS from continuing operations, including, without limitation, changes in accounting standards, to the  extent  necessary  to  prevent  reduction  or  enlargement  of the Participants’  EPS Shares  attributable  to  such  transaction,  circumstance  or  event.  Adjusted Diluted EPS from Continuing Operations for a period of more than one fiscal year, shall mean the Adjusted Diluted EPS from Continuing Operations for each fiscal year (or portion thereof) in such period on a cumulative basis 
(b)    “Board” shall mean the Board of Directors of the Company.  
(c)    “Cause” shall (i) have the meaning provided in a Company or a Subsidiary employment agreement that is in effect and applicable to the Participant, or (ii) mean, if there is no such employment agreement or if such employment agreement contains no such term, unless the Committee determines otherwise, (A) conduct constituting embezzlement, material misappropriation or fraud, whether or not related to the Participant’s employment with the Company or a Subsidiary; (B) conduct constituting a felony, whether or not related to the Participant’s employment with the Company or a Subsidiary; (C) conduct constituting a financial crime, material act of dishonesty or material unethical business conduct, involving the Company or a Subsidiary; (D) willful unauthorized disclosure or use of Company or Subsidiary confidential information; (E) the failure to substantially obey a material lawful directive that is appropriate to the Participant’s position from a superior in his or her reporting line or the Board; (F) the failure or refusal to substantially perform the Participant’s material employment obligations (other than any such failure or refusal resulting from the Participant’s disability); (G) the willful failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, whether or not related to employment with the Company or a Subsidiary, after being instructed by the Company or a Subsidiary to cooperate; (H) the willful destruction of or failure to preserve documents or other material known to be relevant to any investigation referred to in subparagraph (G) above; or (I) the willful inducement of others to engage in the conduct described in subparagraphs (A) – (H). 

4

(d)    “Certificate” shall mean the meaning set forth in Section 1.1 hereof. 
(e)    “Class B Common Stock” shall mean shares of Class B Common Stock, par value $0.001 per share, of the Company. 
(f)    “Code” shall mean the U.S. Internal Revenue Code of 1986, as amended, including any successor law thereto and the rules, regulations and guidance promulgated thereunder. 
(g)    “Committee” shall mean the Compensation Committee of the Board (or such other Committee(s) as may be appointed or designated by the Board to administer the Plan). 
(h)    “Company” shall mean Viacom Inc., a Delaware corporation. 
(i)    “Date of Grant” shall be the date set forth on the Certificate.  
(j)    “Determination Date” means September 30, 2021.
(k)    “EPS” means earnings per share.
(l)    “EPS Shares” means the number of Performance Share Units subject to Section 1.2(a)(2) hereof.
(m)    “Fair Market Value” of a share of Class B Common Stock on a given date shall be the 4:00 p.m. (New York time) closing price on such date on the NASDAQ Stock Exchange or other principal stock exchange on which the Class B Common Stock is then listed. 
(n)    “FY19 Period” means the Company’s 2019 fiscal year.
(o)    “Good Reason” has the meaning assigned to such term in the Participant’s employment agreement with the Company or a Subsidiary.
(p)    “Measurement Period” means the period beginning on October 1, 2018 and ending September 30, 2021; provided, however, that if the Participant’s employment with the Company terminates in a Qualifying Termination, the Measurement Period will be the period beginning October 1, 2018 and ending on the effective date of the Participant’s termination of employment.
(q)    “Participant” shall mean the employee named on the Certificate. 
(r)    “Performance Share Units” shall mean notional units of measurement representing the contractual right granted to the Participant to receive shares of Class B Common Stock and consisting of the Target TSR Shares and the Target EPS Shares set forth in Section 1.2(a) hereof.
(s)    “Permanent Disability” shall have the same meaning as such term or a similar term has in the long-term disability policy maintained by the Company or a Subsidiary thereof for the Participant and that is in effect on the date of the onset of the Participant’s Permanent Disability unless the Committee determines otherwise.

5

(t)    “Plan” shall mean the Viacom Inc. 2016 Long-Term Management Incentive Plan, and as may be amended from time to time.  
(u)    “Qualifying Termination” means (i) the termination of the Participant’s employment by the Company or a Subsidiary other than in a termination of employment for Cause; (ii) in the event the Participant has an employment agreement with the Company or a Subsidiary that contains a Good Reason provision, such Participant’s resignation of employment for Good Reason; (iii) the termination of the Participant’s employment with the Company or a Subsidiary by reason of the Participant’s death or Permanent Disability; or (iv) in the event the Participant has an employment agreement with the Company or a Subsidiary, the non-renewal of such employment agreement at the Company’s or Subsidiary’s election followed by termination of the Participant’s employment with the Company and any Subsidiary within six months of such contract expiration for any reason other than for Cause. 
(v)    “Reference Group” means all companies whose common stock is included in the S&P 500 at the start of the Measurement Period (other than (i) companies that cease to be included in the S&P 500 during the Measurement Period solely due to merger, acquisition, liquidation or similar events fundamentally changing the identity and nature of the company and (ii) companies that cease to be included in the S&P 500 other than on account of events described in the preceding clause (i) and which also cease to have common stock publicly traded on an exchange or on a recognized market system or the over-the-counter market).
(w)    “S&P 500” means the Standard & Poor’s 500 Composite Index.  
(x)    “Section 409A” shall mean Section 409A of the Code and the rules, regulations and guidance promulgated thereunder from time to time. 
(y)    “Target Adjusted Diluted EPS from Continuing Operations for the FY19 Period” means the target adjusted diluted EPS from continuing operations for the Company’s 2019 fiscal year, as determined by the Committee.
(z)    “Target EPS Shares” means the number of EPS Shares determined in Section 1.1 hereof and indicated on the Participant’s PSUs Certificate.  
(aa)     “Target TSR Shares” means the number of TSR Shares determined in Section 1.1 hereof and indicated on the Participant’s PSUs Certificate.
(bb)    “Subsidiary” shall mean a corporation (or a partnership or other enterprise) in which the Company owns or controls, directly or indirectly, 50% or more of the outstanding shares of stock normally entitled to vote for the election of directors (or comparable equity participation and voting power). 
(cc)    “TSR” means for the Class B Common Stock and for the common stock of each company in the Reference Group, the percentage change in value (positive or negative) over the Measurement Period as measured by dividing (i) the sum of (A) each company’s cumulative value of dividends and other distributions in respect of its common stock for the Measurement Period, assuming dividend reinvestment, and (B) the difference (positive or negative) between each company’s common stock price on the first and last day of the 

6

Measurement Period, calculated based on the average closing prices over the 20-day trading period immediately prior to the first day of the Measurement Period and the average closing prices over the 20-day trading period immediately prior to the last day of the Measurement Period, in each case, as reported by Bloomberg L.P. (or such other reporting service that the Committee may designate from time to time); by (ii) the common stock price on the first day of the Measurement Period, calculated on the basis described above.  TSR shall reflect (i) reinvestment of dividends and other distributions and (ii) appropriate and equitable treatment of any reorganizations affecting the corporate structure of the companies in the reference group, in addition to the adjustments for stock splits and reverse stock splits.  TSR will be determined by the Committee in a manner consistent with this definition.  For purposes of computing TSR, if a company has more than one class of common stock outstanding then only the class that is included in the S&P 500 shall be taken into account, and if there is more than one such class the company’s TSR shall be computed using the aggregate values of and distributions on all such classes.
(dd)    “TSR Shares” means the number of Performance Share Units subject to Section 1.2(a)(1) hereof.

ARTICLE IV
MISCELLANEOUS
Section 4.1    No Rights to Awards or Continued Employment.  Neither the Certificate, the Plan nor any action taken in accordance with such documents shall confer upon the Participant any right to be employed by or to continue in the employment of the Company or any Subsidiary, nor to be entitled to any remuneration or benefits not set forth in the Plan or the Certificate, including the right to receive any future awards under the Plan or any other plan of the Company or any Subsidiary or interfere with or limit the right of the Company or any Subsidiary to modify the terms of or terminate the Participant’s employment at any time for any reason.
Section 4.2    Restriction on Transfer.  The rights of the Participant with respect to the Performance Share Units shall not be transferable by the Participant, except by will, the laws of descent and distribution or beneficiary designation; provided that the Committee may permit other transferability, subject to any conditions and limitations that it may, in its sole discretion, impose.  
Section 4.3    Taxes.  The Company or a Subsidiary, as appropriate, shall be entitled to withhold from any payment made to the Participant, a Participant’s estate or any permitted transferee or beneficiary an amount sufficient to satisfy any federal, state, local and/or other tax withholding requirement or satisfy required tax withholding in respect of the delivery of shares of Class B Common Stock upon settlement of Performance Shares Units by having the Company withhold from such delivery shares of Class B Common Stock having a Fair Market Value equal to the amount of such required withholding.
Section 4.4    Stockholder Rights.  The grant of Performance Share Units under the Certificate shall not entitle the Participant or a Participant’s estate, any permitted transferee or beneficiary to any rights of a holder of shares of Class B Common Stock, other than when and until the Participant, the Participant’s estate, the permitted transferee or beneficiary is 

7

registered on the books and records of the Company as a stockholder and shares are delivered to such party upon settlement of the Performance Share Units.  Unless otherwise determined by the Committee in its discretion, no adjustment shall be made for dividends or distributions or other rights in respect of any shares of Class B Common Stock for which the record date is prior to the date on which the Participant, a Participant’s estate or any permitted transferee shall become the holder of such shares of Class B Common Stock. 
Section 4.5    No Restriction on Right of Company to Effect Corporate Changes.  Neither the Plan nor the Certificate shall affect in any way the right or power of the Company or its stockholders to make or authorize any or all adjustments, recapitalizations, reorganizations or other changes in the Company’s capital structure or its business, or any merger or consolidation of the Company, or any issue of stock or of options, warrants or rights to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Class B Common Stock or the rights thereof or which are convertible into or exchangeable for Class B Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise. 
Section 4.6    Section 409A.  If any provision of the Certificate contravenes any regulations or Treasury guidance promulgated under Section 409A or could cause the Participant to be required to recognize income for United States federal income tax purposes with respect to any Performance Share Units before such Performance Share Units are settled or to be subject to any additional tax or interest under Section 409A, such provision of the Certificate may be modified to maintain, to the maximum extent practicable, the original intent of the applicable provision without the imposition of any additional tax or interest under Section 409A.  Moreover, any discretionary authority that the Board or the Committee may have pursuant to the Certificate shall not be applicable to Performance Share Units that are subject to Section 409A to the extent such discretionary authority will contravene Section 409A.
Section 4.7    Amendment.  The Committee shall have broad authority to amend the Certificate without approval of the Participant to the extent necessary or desirable (i) to comply with, or take into account changes in, applicable tax laws, securities laws, accounting rules and other applicable laws, rules and regulations or (ii) to ensure that the Participant is not required to recognize income for United States federal income tax purposes with respect to any Performance Share Units before such Performance Share Units are settled and is not subject to additional tax and interest under Section 409A with respect to any Performance Share Units.  
Section 4.8    Interpretation.  In the event of any conflict between the provisions of the Certificate (including the definitions set forth herein) and those of the Plan, the provisions of the Plan will control.  Additionally, in the event of a conflict or ambiguity between the provisions of the Certificate or the Plan and the provisions of any employment agreement that is in effect and applicable to the Participant with respect to the Performance Share Units, the provisions of such employment agreement shall be deemed controlling to the extent such provisions are consistent with the provisions of the Plan and are more favorable to the Participant than the provisions of the Certificate. 

8

Section 4.9    Breach of Covenants.  In the event that the Committee makes a good faith determination that the Participant committed a material breach of the restrictive covenants relating to non-competition, non-solicitation, confidential information or proprietary property in any employment or other agreement applicable to the Participant during the Participant’s employment or the one year period after termination of the Participant’s employment with the Company or a Subsidiary for any reason, (i) the Participant shall be required to return the shares of Class B Common Stock received by him or her in settlement of the Performance Share Units during the one year period prior to such breach or any time after such breach occurs, or, if the shares of Class B Common Stock received in settlement of the Performance Share Units within the one year period prior to such breach were sold by the Participant, return any proceeds realized on the sale of such shares of Class B Common Stock prior to such breach or any time after such breach occurs and (ii) any unvested Performance Share Units shall be forfeited.  
Section 4.10    Governmental Regulations.  The Performance Share Units shall be subject to all applicable rules and regulations of governmental or other authorities. 
Section 4.11    Headings.  The headings of articles and sections herein are included solely for convenience of reference and shall not affect the meaning of any of the provisions of the Certificate. 
Section 4.12    Governing Law.  The Certificate and all rights hereunder shall be construed in accordance with and governed by the laws of the State of Delaware. 

9BUSINESS DEVELOPMENT AGREEMENT

DeQueen Healthcare Hospital 

 

This document (“Agreement”)
reflects the agreement of iHealthcare Management Company, a Florida Corporation with an address of 3901 NW 28th Street,
2nd Floor, Miami, Florida 33142, (“iHealthcare”) and Jorge A. Perez with an address of 13595 SW 134 Ave,
Suite 209, Miami, Florida, 33186 , (“Perez”) (hereinafter, collectively iHealthcare and Perez are also known as the
“Parties,” or individually as a “Party”) to engage in business on the terms set forth below, as well as
such other terms and conditions as the Parties may agree.  The Parties may reduce the terms listed below to a more complete
written agreement, but they are not required to do so.

 

WHEREAS, iHealthcare is in the hospital management
business through its wholly owned subsidiary iHealthcare Management Company and desires to expand its hospital management business; 

WHEREAS, Perez has demonstrated a track record
of developing and securing hospital management contracts; 

WHEREAS, the Parties desire to use their respective
assets for the common goal of assisting the rural healthcare landscape, driving healthcare insurance costs down, providing innovative
products and tools, and growing a small footprint of Hospitals and Service Offerings into a major sustainable business that will
serve communities throughout the United States; 

WHEREAS, the Parties consider their ongoing
relationship and potential business relationship to be independently valuable;  

NOW, THEREFORE, for and in consideration of the ongoing
and potential relationship between iHealthcare and Perez, and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, iHealthcare and Perez, intending to be legally bound, do hereby agree as follows and acknowledge
the above recitals as true and incorporated herein, and: 

 

1)BUSINESS
DEVELOPMENT ENGAGEMENT:  

 

a)iHealthcare
hereby engages Perez to deliver certain valid, binding, exclusive and executed hospital management contracts for new business for
and on behalf of iHealthcare Management Company;  

b)Perez
shall utilize the iHealthcare Management Company contract template [attached]; 

Business Agreement

Page 1 of 13

c)Perez
shall obtain any required consents, authorizations and binding approvals necessary to deliver an executed binding ten-year contracts
for hospital management services to iHealthcare Management Company;  

d)Perez
will ensure iHealthcare is the exclusive provider of management services under these new agreements; 

e)Perez
will ensure that no liabilities of any kind which nay have incurred prior to the new contract inception date will transfer, assign
or inure to iHealthcare Management Company;  

f)The
target inception date will be January 7, 2019 and limited only to the following target hospital: DeQueen Healthcare Hospital LLC. 

 

2)TERMS.
 The Parties herby agree as follows:  

 

a)The
parties acknowledge that under this Business Development Agreement, the Parties agree to mutually work together to grow the business
model and create new revenue lines that are currently not operational.  

b)The
contracts, once executed, must have a 10-year non-cancelable term with renewals. 

 

3)CONSIDERATION:
With this in mind, the consideration for this business development effort will be a Success Fee structured as a Promissory Note
and Stock as follows:  

 

a)Success
Fee: $800,000.00 

1.The
Success Fee will be earned upon delivery of a legally binding and executed Management and Administrative Services Agreement.  
The Success Fee is based on a negotiated value.   

b)Terms
in General:  

1.iHealthcare
shall issue a Promissory Note for 100% of the agreed value under this Business Development Agreement.  

2.Promissory
Note will have a 10 year term and 4% simple annual interest on the unpaid balance.  

3.Payment:
Promissory Note may be prepaid without penalty, in full or in part, in cash or common stock at the option of iHealthcare. 

4.Default:
In the event of a default, iHealthcare shall be granted 45 days to cure, as stipulated in the Management and Administrative Services
Agreement. 

5.Security:
In the event of failure to cure the default after the 45-day period and remedy specified in the Management and Administrative Services
Agreement, the management agreement shall be surrendered to the Lender as security. 

6.Adjustments:
In the event that any of the named hospitals closes or is placed in receivership, files for bankruptcy, becomes insolvent or is
assigned to creditors, the portion of the Success Fee allocated to that specific hospital only shall be adjusted accordingly and
the associated portion of the Promissory Note shall be adjusted to reflect the change in event and the balance due shall be reduced
to reflect that portion for the remaining term of the note.  

7.Offsets:
This Agreement is based on the premise that the Hospital Management and Administrative Services Agreement will be in effect for
10 full years which enables iHealthcare to fund the payments for the Promissory Note during this term. Therefore,  

Business Agreement

Page 2 of 13

there may be a pro rata offset to the balance
of the Promissory Note if one or more of the following occur during the ten-year term:

a)Any
early cancellation or termination of the contract that is not as a result of breach of contract by iHealthcare. 

b)Failure
to enforce the tagalong provision of the contract. 

c)A
Hospital ownership action to close the hospital. 

d)Loss
or suspension of Hospital License or Medicare Provider status relating to events occurring prior to closing. 

e)In
the event that the hospital closes or is placed in receivership, files for bankruptcy, becomes insolvent or is assigned to creditors,
the portion of the Success Fee listed in the Business Development Agreement shall be adjusted accordingly and the remaining portion
of this Promissory Note shall be adjusted to reflect the change in event and the balance due shall be reduced to reflect that portion
for the remaining term of the note. 

f)Any
Offset is subject to arbitration and other remedies as specified in the Hospital Management and Administrative Services Agreement.
  

g)Liabilities
incurred prior to closing.  

 

c)Terms
of Preferred B Stock from iHealthcare, Inc:  

 

1.Success
Event: Final delivery of a fully executed, legally binding Management and Administrative Services Agreement for DeQueen Healthcare
Hospital LLC. 

2.Preferred
Series B Shares: A total of 45,460 Preferred Series B Shares par value $0.0001 per share will be allocated to the Perez -Tio
Family Trust, as part of the Success Fee of this Agreement as earned per contract: 

a)DeQueen
Healthcare Hospital LLC: 45,460 shares 

3.Conversion
Value: One share of Preferred B for one share of Common Stock - Converted at the option of the Holder.  

4.Restrictions:
Shares will be restricted for 6 months from issuance per SEC regulations. 

5.COC:
Accelerated Conversion and call back on then existing terms at Change of Control. 

6.Call
Option: iHealthcare may call or force conversion all or part of the stock in the event of a recapitalization or liquidation
event or public offering.  

7.Voting:
Preferred B Shares are voting as one vote per share. 

8.Reserves:
iHealthcare Inc. shall reserve sufficient shares of Preferred B and Common stock to meet the obligations of this agreement. 

9.Interest:
No interest is paid or due on equity offers. 

10.Conditions:
The specific terms of Preferred B Shares are set and fixed by iHealthcare’s Articles of Incorporation. 

 

d)Terms
of Preferred C Stock from iHealthcare Inc:     

 

1.Success
Event: Final delivery of a fully executed, legally binding Management and Administrative Services Agreement for DeQueen Healthcare
Hospital LLC.  

Business Agreement

Page 3 of 13

2.Preferred
Series C Shares: A total of 45,460 Preferred Series C Shares par value $0.0001 per share will be allocated to the Perez -Tio
Family Trust, as part of the Success Fee of this Agreement as earned per contract: 

a)Dequeen
Healthcare Hospital LLC: 45,460 shares. 

3.Terms:
Terms will be governed by the Certificate of Designation for Preferred C Shares filed with the State of Delaware along with Board
Resolution. 

These shares shall be earned as follows  

4.Convertible
Note: The 45,460 Preferred Shares C will be issued as a Convertible Note to the Perez – Tio Family Trust. 

5.Conversion:
The Conversion value is one share of Preferred Stock to one share of Common Stock 

6.Value
Assurance Guarantee:  When converted from Preferred Shares to Common Stock, iHealthcare guarantees a minimum value, only
on the date of conversion, of $1.00 per share converted. If the value of the Common Stock trading on that day is below $1.00 per
share, the company will issue sufficient additional Common Stock share’s so that the total value of the redeemed converted
Preferred Stock redeemed to Common Stock equals a minimum of $1.00 per share based on the conversion date’s closing per share
value of Common Stock. If the value is in excess of $1.00 per share on the date of conversion, the share conversion remains 1:1
and the Holder shall retain the upside value, if any. Common stock must be trading on a public exchange to qualify. 

7.Restricted
Share Tranches and Vesting: When each restricted share tranche reaches maturity in the Convertible Note on the following schedule
of performance, the note will covert to Preferred Shares as listed, at the option of the Holder.  

a)45,460
shares vested upon closing.   

8.Restricted
Share Conversion Schedule: Vested Preferred shares may convert and then shall be exercisable for conversion to Common Stock,
all or in part or none, at the option of the Holder only after the closing of the new management contracts, the following schedule:
 

a)45,460
shares – 12 months from date of closing. 

1.COC:
Accelerated Conversion and call back on then existing terms at Change of Control. 

2.Call
Option: iHealthcare may call or force conversion all or part of the stock in the event of a recapitalization or liquidation
event or public offering.  

3.Voting:
Preferred C Shares are non-voting until converted to Common Stock.  

4.Reserves:
iHealthcare Inc. shall reserve sufficient shares of Preferred C and Common stock to meet the obligations of this agreement. 

5.Interest:
No interest is paid or due on equity offers. 

 

1)NONDISCLOSURE
AND NONUSE OF CONFIDENTIAL INFORMATION.   

 

a)The
Parties acknowledge that they each have, may obtain or may develop certain Confidential Information (as defined below) in the ordinary
course of their business and that the Parties may learn of, or have access to, each other’s Confidential Information during
the course of their business relationship with each other. 

Business Agreement

Page 4 of 13

b)For
the purposes of this Agreement, the term “Confidential Information” shall mean any and all confidential and/or proprietary
knowledge, data, information or trade secrets used, obtained, or developed by or for a Party that is treated as confidential by
that Party, or is of a nature that should reasonably be understood by the receiving Party to be confidential, and is not and otherwise
would not be regularly and routinely available to the general public.  The term “Confidential Information,” includes,
without limitation, information and data, whether in written, oral, graphic or machine-readable form, but shall not include that
which is (i) publicly available by other than unauthorized means, (ii) disclosed to others by the disclosing Party or other proper
Party without restriction, (iii) rightfully received from a third party without restriction, (iv) discoverable by common observation,
through publicly or commercially available sources, or by inspection or analysis of products in the market place, or (v) general
skill and knowledge. 

 

c)The
receiving Party hereby agrees to comply with any and all of the disclosing Party’s commercially reasonable policies and procedures
for the protection of Confidential Information and, except as required by law or by the nature of receiving Party’s duties
for the disclosing Party or with the prior written approval of an authorized officer of the disclosing Party, receiving Party will
not, during its business relationship with disclosing Party or at any time thereafter, use or disclose, directly or indirectly
in any manner, any Confidential Information of the disclosing Party, including the fact that Confidential Information has been
made available to the receiving Party for any purpose other than in furtherance of the business relationship with disclosing Party.
The provisions of this Agreement regarding disclosure and use of Confidential Information shall survive the termination or expiration
of this Agreement and shall be effective forever.  

 

d)The
receiving Party hereby agrees that any Confidential Information is and shall remain the sole and exclusive property of the disclosing
Party for use in the disclosing Party’s business and shall be used solely in connection with furtherance of the business
relationship with disclosing Party and shall not be used by receiving Party, directly or indirectly, in any other manner whatsoever.
 Under no circumstances whatsoever shall receiving Party have any proprietary or other legal right to the disclosing Party’s
Confidential Information during, or subsequent to the termination or cessation of, the business relationship of the Parties. 

 

e)The
receiving Party hereby agrees not to disclose, copy, or remove from the premises of the disclosing Party any documents, records,
tapes or other media or format that contain or may contain Confidential Information, except as required by the nature of receiving
Party’s duties for the disclosing Party or as otherwise approved in writing by an authorized officer of the disclosing Party.
 Upon termination or cessation of the business relationship of the Parties, regardless of the reason for such termination
or cessation, receiving Party hereby agrees to return immediately to the disclosing Party, or destroy at the disclosing Party’s
discretion, all originals and copies of documents, records, tapes, or any other media or format that contain or may contain Confidential
Information. Furthermore, all Confidential Information belonging to disclosing Party  

Business Agreement

Page 5 of 13

will be and remain solely the property of disclosing
Party.  Any such return or destruction, as applicable, of Confidential Information shall be certified in writing by receiving
Party to disclosing Party within three (3) days of the return or destruction. Any Confidential Information that is not returned
or destroyed, including any oral Confidential Information, will continue to be kept confidential and subject of the terms of this
Agreement.

 

f)In
the event receiving Party is legally compelled to disclose Confidential Information belonging to disclosing Party, the receiving
Party shall promptly notify disclosing Party of each such requirement so that disclosing Party may seek a protective order or other
appropriate remedy and/or waive compliance with the provisions of this Agreement. In any such event, receiving Party will only
disclose such Confidential Information that s/he/it is advised by counsel to disclose and legally required to be disclosed and
shall exercise reasonable efforts to obtain assurance that confidential treatment will be accorded to such Confidential Information. 

 

g)The
receiving Party’s access to Confidential Information shall automatically terminate at the termination or expiration of the
relationship between the Parties with respect to the subject matter of this Agreement. Notwithstanding the foregoing, disclosing
Party may immediately terminate access to its Confidential Information at any time. 

 

h)Neither
of the Parties to this Agreement shall make any announcement of the proposed transaction contemplated by this Agreement, without
the prior written approval of the other, which approval will not be unreasonably withheld or delayed.   The foregoing
shall not restrict in any respect the Party’s ability to communicate information concerning this Agreement, and the transactions
contemplated hereby, to their respective affiliates’, officers, directors, employees and professional advisers; and, (to
the extent relevant), to third parties whose consent is required in connection with the transaction contemplated by this Agreement. 

 

 

2)NON-CIRCUMVENTION.
  

 

a)The
Parties understand that in the performance of this Agreement they may each reveal to each other, contacts and relationships which
are not otherwise known to the general public or to whom the general public may otherwise not have access. 

 

b)The
Parties will not in any manner solicit, nor do business in any manner with individuals, entities, related parties or their affiliates
(“Source(es)”), which were made available to them through this Agreement by the other Party, without the express permission
of the party who made available the Source; 

 

c)Source
shall include, without limitation, any contact, contract or transaction with all persons, companies (e.g., limited liability companies,
etc.), firms, partnerships (e.g., general partnerships, limited liability partnerships, etc.), corporations (e.g., domestic, foreign,
international), co-ventures, joint ventures, trusts or any other entity with which  

Business Agreement

Page 6 of 13

they or any associate, agent, employee, or representative
are or may be in any way associated or concerned, no matter the country of origin or origination of the association.

 

d)A
Party will not attempt either directly or indirectly, for the purposes of circumventing the other Party, to make any contact with
any individual or entity, including without limitation relationships, customers or clients, whose identity is made known to one
Party solely in connection with their relationship with the other Party, as contemplated by this Agreement, without the prior written
approval of such other Party. The identity of such individuals and entities shall be deemed proprietary and valuable to the Party
in whose knowledge, such identity currently resides. 

 

e)The
Parties will maintain complete confidentiality regarding each other’s Sources and will disclose such Sources only to third
parties only pursuant to the express written permission of the Party who made available the Source; 

 

f)The
Parties will not disclose names, addresses, e-mail address, telephone and tele-fax or telex numbers to any Sources, to third parties
and the Parties each recognize such Sources as the exclusive property of the providing Party and they will not enter into any direct
negotiations or transactions with such Sources revealed by the other Party; 

 

g)The
Parties further undertake not to enter into business transaction with banks, iHealthcare’s sources of funds or other bodies,
the names of which have been provided by one of the Parties to this agreement, unless written permission has been obtained from
the other Party to do so.  

 

h)The
Parties also undertake not to make use of a third party to circumvent this clause. 

 

3)COVENANT
NOT TO COMPETE 

 

a)In
accordance with this Agreement, the Parties will gain knowledge of certain proprietary information belonging to the other Party
and valuable confidential business or professional information. The Parties may also acquire substantial relationships with specific
prospective or existing customers or clients and gain customer or client goodwill associated with the Parties’ ongoing business
or professional practice. The Parties may additionally be provided with extraordinary or specialized training, specific to the
Parties’ field of business and specific business. In light of the above, the Parties acknowledges and agrees that the they
each are entitled to a Covenant Not To Compete and such restraint is reasonably necessary to protect the legitimate business interest
or interests of the Parties, to the extent that there is an Ongoing Entity. 

 

b)Accordingly,
during the Parties’ relationship with each other and for a period of 10 years from the date of this Agreement, for any reason,
the Parties shall not, directly or indirectly, through another person or entity, compete with the each other anywhere where the
Ongoing Entity does business or owns an interest in or, as principal, agent, contractor, consultant, or employee or otherwise,
engages in activities for or renders  

Business Agreement

Page 7 of 13

services to any firm or business that competes
with the Ongoing Entity, “Compete” being defined as conducting business in the marketplace, contracting for hospital
management services and all related marketing models and business models. The territory shall be deemed to initially be the United
States of America and such other locations as the Ongoing Entity may be doing business at any time and also those States in which
Ongoing Entity has reasonably advanced toward doing business.

 

c)“Compete”
shall additionally include without limitation, soliciting, providing services to, or otherwise engaging in a business transaction
with customers or clients of the Ongoing Entity or any affiliate of the Ongoing Entity, or directly or indirectly soliciting for
employment any of the Ongoing Entity’s employees, or the employees of any of the Ongoing Entity’s affiliates. 

 

4)INDEMNIFICATION
AND MUTUAL HOLD HARMLESS 

 

(a) Perez shall indemnify, defend and hold harmless iHealthcare
and its affiliates, their respective shareholders, officers, directors, employees, and agents, against and in respect of any and
all losses, claims, damages, causes of action, actions, obligations, liabilities, deficiencies, suits, proceedings, actual out-of-pocket
obligations and expenses (including cost of investigation, interest, penalties and reasonable attorneys' fees) (collectively, "Losses")
arising out of or due to the operation of the Business or relating to events prior to closing by iHealthcare, its affiliates, agents,
servants and/or employees after Closing  under the provisions of this Agreement. The obligations set forth in this Section
7(a) shall survive for a period of ten (10 years following the Expiration Date.

 

(b) iHealthcare shall indemnify, defend and hold harmless
Perez and its affiliates, their respective shareholders, officers, directors, employees, and agents, against and in respect of
any and all Losses arising out of or due to gross negligence of the Manager, its affiliates, agents, servants and/or employees
prior to and during the commencement of the term of this Agreement. The obligations set forth in this Section 7(b) shall survive
for a period of ten (10) years following the Expiration Date.

 

(c) If a party entitled to indemnification (the "Indemnitee")
receives notice of any claim or the commencement of any action or proceeding with respect to which a party is obligated to provide
indemnification (the "Indemnifying Party") pursuant to subsections (a) and (b) of this Section, the Indemnitee shall
promptly give the Indemnifying Party notice thereof (Indemnification Notice"). Such Indemnification Notice shall be a condition
precedent to any liability of the Indemnifying Party under the provisions for indemnification contained in this Agreement. Except
as provided below, the Indemnifying Party may compromise, settle or defend, at such Indemnifying Party's own expense and by such
Indemnifying Party's own counsel, any such matter involving the asserted liability of the Indemnitee. In any event, the Indemnitee,
the Indemnifying Party and the Indemnifying Party's counsel shall cooperate in the compromise of, or defense against, any such
asserted liability. If the Indemnifying Party provides the Indemnitee a defense to a third party claim at the Indemnifying Party's
cost with a qualified attorney, Indemnitee may participate and/or monitor the defense with an attorney of the Indemnitee's selection
(at the Indemnitee's own expense). Provided that the Indemnifying Party pays for the full cost of the settlement of any claim,

Business Agreement

Page 8 of 13

the Indemnifying Party may settle any claim without the consent
of the Indemnitee. If the Indemnifying Party chooses to defend any claim, the Indemnitee shall make available to the Indemnifying
Party any books, records or other documents within its control that are necessary or appropriate for such defense.

 

8. LIMITATION OF LIABILITY

 

NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY SPECIAL,
CONSEQUENTIAL, INCIDENTAL, PUNITIVE, OR INDIRECT DAMAGES ARISING FROM OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF
ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. NOTWITHSTANDING THE FOREGOING, NOTHING IN THIS PARAGRAPH IS INTENDED TO LIMIT OR
RESTRICT THE INDEMNIFICATION RIGHTS OR OBLIGATIONS OF ANY PARTY UNDER SECTION 7, OR DAMAGES AVAILABLE FOR BREACHES OF THE OBLIGATIONS
SET FORTH IN SECTION 7.

 

a)Upon
request of any Party to this Agreement, the requested Party(ies) shall take such further actions, and shall cause its (their) personnel,
agents, and employees to take such further actions, including execution and delivery of documents, that may reasonably be deemed
necessary or desirable to accomplish or evidence more further the objectives and intent of this Agreement.   

 

b)This
Agreement contains the complete understanding between the Parties and shall as of the date hereof, supersede all other agreements,
whether they are written or oral, between the Parties concerning the particular subject matter.  Paragraphs 2 through 11 constitute
a binding contract and will continue in full force and effect surviving the termination of this Agreement.  Paragraph 1 is
a statement of interest and intent to do business, but as set forth above, Paragraph 1 shall become binding to the extent that
the Parties complete Due Diligence (as defined below) and iHealthcare elects to proceed, or where iHealthcare provides any capital
to Perez, without a more formal writing, the substantive terms herein shall be conclusive as to the agreement of the Parties.  Further,
to the extent that additional substantive terms are in issue, the course of conduct of the Parties shall be controlling as to such
terms. 

 

c)No
waiver or modification of this Agreement or any covenant, condition or limitation herein contained shall be valid and no evidence
of waiver or modification shall be offered or received in evidence in any proceeding, arbitration or litigation between the Parties
hereto arising out of or affecting this Agreement or the rights or obligations of the Parties hereunder, unless such waiver or
modification is in writing duly signed by all Parties, or in an email exchange where both Parties have commented. 

 

d)All
agreements and covenants contained herein are severable, and in the event that any of them shall be held to be invalid by any competent
court, this Agreement shall be interpreted as if such invalid agreement or covenant is not contained herein. 

 

e)The
failure of any Party to insist in any one or more instances upon performance of any  

Business Agreement

Page 9 of 13

terms or conditions of this Agreement shall not
be construed as a waiver of future performance of any such term, covenant, or condition, but the obligations of any Party with
respect thereto shall continue in full force and effect.

 

f)Neither
this Agreement nor any interest herein may be assigned in whole or in part by any Party hereto without the prior written consent
of all other Parties. 

 

g)The
terms and existence of this Agreement are confidential, and neither the contents nor its details of the Agreement may be shown
or disclosed by either Party, except to those individuals with who have a need to know as a result of being involved in or related
to this Agreement. 

 

h)In
addition to any remedies under the applicable law, the Parties recognize that any breach or violation of any provision of this
Agreement may cause irreparable harm to the other Party, which money damages may not necessarily remedy. Therefore, upon any actual
or impending violation of any provision of this Agreement, either Party may obtain from any court of competent jurisdiction a preliminary,
temporary or permanent injunction, restraining or enjoining such violation by the other Party or any entity or person acting in
concert with that Party. 

 

i)This
Agreement shall be governed by and interpreted in accordance with the laws of the State of Florida. IF A DISPUTE ARISES, THE PARTIES
WILL: (a) RESOLVE ALL DISPUTES BY BINDING ARBITRATION HELD IN MIAMI-DADE COUNTY, FLORIDA BEFORE A SINGLE ARBITRATOR FROM JUDICIAL
ARBITRATION AND MEDIATION SERVICES, INC. (“JAMS”); AND (b) WAIVE ANY RIGHT TO CIVIL TRIAL BY JUDGE OR JURY.  Notwithstanding
the foregoing, all claims alleging violation of restrictive covenants, mishandling of Confidential Information, or transgression
of intellectual property rights, shall be subject to the exclusive jurisdiction, in Miami, Florida, of either the Florida state
courts or the US District Court.  Before accepting appointment, the arbitrator shall agree: (a) that the arbitrator’s
award shall be made within nine (9) months of the filing of a notice of intention (or demand) to arbitrate  (but it may be
extended by written agreement of the parties); (b) to base any decision or award on governing law; (c) to not award punitive or
other damages that are not measured by the prevailing party’s actual damages, except as may be required by statute; and (d)
to issue an award in writing within ten (10) days of concluding the presentation of evidence and briefs.  Judgment may be
entered in any court having jurisdiction thereof.  The prevailing party shall be entitled to recover from the other party
its costs and expenses, including reasonable attorney’s fees. 

 

j)Authority:
Perez have full power and authority and are legally authorized to execute and bind the hospitals to new management contracts for
the benefit of iHealthcare Management Company. 

 

 

a.The
Parties further agree: 

Business Agreement

Page 10 of 13

1.To
the extent that they are not in conflict with this document, that the use of electronic messages shall create valid and enforceable
rights and obligations between them; and 

 

2.That
to the extent permitted under the applicable law, electronic messages shall be admissible as evidence, provided that such electronic
messages are sent to addresses and in formats, if any, designated either expressly or implicitly by the addresses; and  

 

3.Not
to challenge the validity of any communication or agreement between them solely on the ground of the use of electronic means, whether
or not such use was reviewed by any natural person. 

 

1.This
Agreement may be executed in separate counterparts all of which shall be deemed to be one (1) agreement. 

 

 

 

SIGNATURE PAGE TO FOLLOW

Business Agreement

Page 11 of 13

 

IN WITNESS WHEREOF, the Parties have caused this Agreement
to be Accepted and Agreed to as of January 7, 2019

 

 

 

JORGE A. PEREZiHealthcare Management Company 

 

 

 

 

                 
                         

By: /s/ Jorge A. Perez By:  /s/ Noel
Mijares   

Jorge A. Perez                         
Noel Mijares, Chief Executive Officer 

Business Agreement

Page 12 of 13

 

BUSINESS DEVELOPMENT AGREEMENT

Fulton Medical Center

 

This document (“Agreement”)
reflects the agreement of iHealthcare Management Company, a Florida Corporation with an address of 3901 NW 28th Street,
2nd Floor, Miami, Florida 33142, (“iHealthcare”) Jorge A. Perez with an address of 13595 SW 134 Avenue,
Suite 209, Miami, Florida, 33186 , (“Perez”) (hereinafter, collectively iHealthcare and Perez are also known as the
“Parties,” or individually as a “Party”) to engage in business on the terms set forth below, as well as
such other terms and conditions as the Parties may agree.  The Parties may reduce the terms listed below to a more complete
written agreement, but they are not required to do so.

 

WHEREAS, iHealthcare is in the hospital management
business through its wholly owned subsidiary iHealthcare Management Company and desires to expand its hospital management business; 

WHEREAS, Perez has demonstrated a track record
of developing and securing hospital management contracts; 

WHEREAS, the Parties desire to use their respective
assets for the common goal of assisting the rural healthcare landscape, driving healthcare insurance costs down, providing innovative
products and tools, and growing a small footprint of Hospitals and Service Offerings into a major sustainable business that will
serve communities throughout the United States; 

WHEREAS, the Parties consider their ongoing
relationship and potential business relationship to be independently valuable;  

NOW, THEREFORE, for and in consideration of the ongoing
and potential relationship between iHealthcare and Perez, and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, iHealthcare and Perez, intending to be legally bound, do hereby agree as follows and acknowledge
the above recitals as true and incorporated herein, and: 

 

1)BUSINESS
DEVELOPMENT ENGAGEMENT:  

 

a)iHealthcare
hereby engages Perez to deliver certain valid, binding, exclusive and executed hospital management contracts for new business for
and on behalf of iHealthcare Management Company;  

b)Perez
shall utilize the iHealthcare Management Company contract template [attached]; 

Business Agreement

Page 1 of 13

c)Perez
shall obtain any required consents, authorizations and binding approvals necessary to deliver an executed binding ten-year contracts
for hospital management services to iHealthcare Management Company;  

d)Perez
will ensure iHealthcare is the exclusive provider of management services under these new agreements; 

e)Perez
will ensure that no liabilities of any kind which nay have incurred prior to the new contract inception date will transfer, assign
or inure to iHealthcare Management Company;  

f)The
target inception date will be January 7, 2019 and limited only to the following target hospital: Fulton Medical Center LLC. 

 

2)TERMS.
 The Parties herby agree as follows:  

 

a)The
parties acknowledge that under this Business Development Agreement, the Parties agree to mutually work together to grow the business
model and create new revenue lines that are currently not operational.  

b)The
contracts, once executed, must have a 10-year non-cancelable term with renewals. 

 

3)CONSIDERATION:
With this in mind, the consideration for this business development effort will be a Success Fee structured as a Promissory Note
and Stock as follows:  

 

a)Success
Fee: $950,000.00 

1.The
Success Fee will be earned upon delivery of a legally binding and executed Management and Administrative Services Agreement.  
The Success Fee is based on a negotiated value.   

 

b)Terms
in General:  

1.iHealthcare
shall issue a Promissory Note for 100% of the agreed value under this Business Development Agreement.  

2.Promissory
Note will have a 10 year term and 4% simple annual interest on the unpaid balance.  

3.Payment:
Promissory Note may be prepaid without penalty, in full or in part, in cash or common stock at the option of iHealthcare. 

4.Default:
In the event of a default, iHealthcare shall be granted 45 days to cure, as stipulated in the Management and Administrative Services
Agreement. 

5.Security:
In the event of failure to cure the default after the 45-day period and remedy specified in the
Management and Administrative Services Agreement, the management agreement shall be surrendered to the Lender as security. 

6.Adjustments:
In the event that any of the named hospitals closes or is placed in receivership, files for bankruptcy, becomes insolvent or is
assigned to creditors, the portion of the Success Fee allocated to that specific hospital only shall be adjusted accordingly and
the associated portion of the Promissory Note shall be adjusted to reflect the change in event and the balance due shall be reduced
to reflect that portion for the remaining term of the note.  

7.Offsets:
This Agreement is based on the premise that the Hospital Management and Administrative Services Agreement will be in effect for
10 full years which enables iHealthcare to fund the payments for the Promissory Note during this term. Therefore,  

Business Agreement

Page 2 of 13

there may be a pro rata offset to the balance
of the Promissory Note if one or more of the following occur during the ten-year term:

a)Any
early cancellation or termination of the contract that is not as a result of breach of contract by iHealthcare. 

b)Failure
to enforce the tagalong provision of the contract. 

c)A
Hospital ownership action to close the hospital. 

d)Loss
or suspension of Hospital License or Medicare Provider status relating to events occurring prior to closing. 

e)In
the event that the hospital closes or is placed in receivership, files for bankruptcy, becomes insolvent or is assigned to creditors,
the portion of the Success Fee listed in the Business Development Agreement shall be adjusted accordingly and the remaining portion
of this Promissory Note shall be adjusted to reflect the change in event and the balance due shall be reduced to reflect that portion
for the remaining term of the note. 

f)Any
Offset is subject to arbitration and other remedies as specified in the Hospital Management and Administrative Services Agreement.
  

g)Liabilities
incurred prior to closing.  

 

c)Terms
of Preferred B Stock from iHealthcare, Inc:  

 

1.Success
Event: Final delivery of a fully executed, legally binding Management and Administrative Services Agreement for Fulton Medical
Center LLC.  

2.Preferred
Series B Shares: A total of 45,460 Preferred Series B Shares par value $0.0001 per share will be allocated to the Perez -Tio
Family Trust, as part of the Success Fee of this Agreement as earned per contract: 

a)
Fulton Medical Center LLC: 45,460 shares 

3.Conversion
Value: One share of Preferred B for one share of Common Stock - Converted at the option of the Holder.  

4.Restrictions:
Shares will be restricted for 6 months from issuance per SEC regulations. 

5.COC:
Accelerated Conversion and call back on then existing terms at Change of Control. 

6.Call
Option: iHealthcare may call or force conversion all or part of the stock in the event of a recapitalization or liquidation
event or public offering.  

7.Voting:
Preferred B Shares are voting as one vote per share. 

8.Reserves:
iHealthcare Inc. shall reserve sufficient shares of Preferred B and Common stock to meet the obligations of this agreement. 

9.Interest:
No interest is paid or due on equity offers. 

10.Conditions:
The specific terms of Preferred B Shares are set and fixed by iHealthcare’s Articles of Incorporation. 

 

 

 

 

d)Terms
of Preferred C Stock from iHealthcare Inc:     

Business Agreement

Page 3 of 13

1.Success
Event: Final delivery of a fully executed, legally binding Management and Administrative Services Agreement for Fulton Medical
Center LLC. 

2.Preferred
Series C Shares: A total of 45,460 Preferred Series C Shares par value $0.0001 per share will be allocated to the Perez -Tio
Family Trust, as part of the Success Fee of this Agreement as earned per contract: 

a)Fulton
Medical Center LLC: 45,460 shares. 

3.Terms:
Terms will be governed by the Certificate of Designation for Preferred C Shares filed with the State of Delaware along with Board
Resolution. 

These shares shall be earned as follows  

4.Convertible
Note: The 45,460 Preferred Shares C will be issued as a Convertible Note to the Perez – Tio Family Trust. 

5.Conversion:
The Conversion value is one share of Preferred Stock to one share of Common Stock 

6.Value
Assurance Guarantee:  When converted from Preferred Shares to Common Stock, iHealthcare guarantees a minimum value, only
on the date of conversion, of $1.00 per share converted. If the value of the Common Stock trading on that day is below $1.00 per
share, the company will issue sufficient additional Common Stock share’s so that the total value of the redeemed converted
Preferred Stock redeemed to Common Stock equals a minimum of $1.00 per share based on the conversion date’s closing per share
value of Common Stock. If the value is in excess of $1.00 per share on the date of conversion, the share conversion remains 1:1
and the Holder shall retain the upside value, if any. Common stock must be trading on a public exchange to qualify. 

7.Restricted
Share Tranches and Vesting: When each restricted share tranche reaches maturity in the Convertible Note on the following schedule
of performance, the note will covert to Preferred Shares as listed, at the option of the Holder.  

a)45,460
shares vested upon closing.   

8.Restricted
Share Conversion Schedule: Vested Preferred shares may convert and then shall be exercisable for conversion to Common Stock,
all or in part or none, at the option of the Holder only after the closing of the new management contracts, the following schedule:
 

a)45,460
shares – 12 months from date of closing. 

1.COC:
Accelerated Conversion and call back on then existing terms at Change of Control. 

2.Call
Option: iHealthcare may call or force conversion all or part of the stock in the event of a recapitalization or liquidation
event or public offering.  

3.Voting:
Preferred C Shares are non-voting until converted to Common Stock.  

4.Reserves:
iHealthcare Inc. shall reserve sufficient shares of Preferred C and Common stock to meet the obligations of this agreement. 

5.Interest:
No interest is paid or due on equity offers. 

 

 

 

 

1)NONDISCLOSURE
AND NONUSE OF CONFIDENTIAL INFORMATION.   

Business Agreement

Page 4 of 13

a)The
Parties acknowledge that they each have, may obtain or may develop certain Confidential Information (as defined below) in the ordinary
course of their business and that the Parties may learn of, or have access to, each other’s Confidential Information during
the course of their business relationship with each other. 

 

b)For
the purposes of this Agreement, the term “Confidential Information” shall mean any and all confidential and/or proprietary
knowledge, data, information or trade secrets used, obtained, or developed by or for a Party that is treated as confidential by
that Party, or is of a nature that should reasonably be understood by the receiving Party to be confidential, and is not and otherwise
would not be regularly and routinely available to the general public.  The term “Confidential Information,” includes,
without limitation, information and data, whether in written, oral, graphic or machine-readable form, but shall not include that
which is (i) publicly available by other than unauthorized means, (ii) disclosed to others by the disclosing Party or other proper
Party without restriction, (iii) rightfully received from a third party without restriction, (iv) discoverable by common observation,
through publicly or commercially available sources, or by inspection or analysis of products in the market place, or (v) general
skill and knowledge. 

 

c)The
receiving Party hereby agrees to comply with any and all of the disclosing Party’s commercially reasonable policies and procedures
for the protection of Confidential Information and, except as required by law or by the nature of receiving Party’s duties
for the disclosing Party or with the prior written approval of an authorized officer of the disclosing Party, receiving Party will
not, during its business relationship with disclosing Party or at any time thereafter, use or disclose, directly or indirectly
in any manner, any Confidential Information of the disclosing Party, including the fact that Confidential Information has been
made available to the receiving Party for any purpose other than in furtherance of the business relationship with disclosing Party.
The provisions of this Agreement regarding disclosure and use of Confidential Information shall survive the termination or expiration
of this Agreement and shall be effective forever.  

 

d)The
receiving Party hereby agrees that any Confidential Information is and shall remain the sole and exclusive property of the disclosing
Party for use in the disclosing Party’s business and shall be used solely in connection with furtherance of the business
relationship with disclosing Party and shall not be used by receiving Party, directly or indirectly, in any other manner whatsoever.
 Under no circumstances whatsoever shall receiving Party have any proprietary or other legal right to the disclosing Party’s
Confidential Information during, or subsequent to the termination or cessation of, the business relationship of the Parties. 

 

e)The
receiving Party hereby agrees not to disclose, copy, or remove from the premises of the disclosing Party any documents, records,
tapes or other media or format that contain or may contain Confidential Information, except as required by the nature of receiving
Party’s duties for the disclosing Party or as otherwise approved in writing by an authorized officer of the disclosing Party.
 Upon termination or cessation of the  

Business Agreement

Page 5 of 13

business relationship of the Parties, regardless
of the reason for such termination or cessation, receiving Party hereby agrees to return immediately to the disclosing Party, or
destroy at the disclosing Party’s discretion, all originals and copies of documents, records, tapes, or any other media or
format that contain or may contain Confidential Information. Furthermore, all Confidential Information belonging to disclosing
Party will be and remain solely the property of disclosing Party.  Any such return or destruction, as applicable, of Confidential
Information shall be certified in writing by receiving Party to disclosing Party within three (3) days of the return or destruction.
Any Confidential Information that is not returned or destroyed, including any oral Confidential Information, will continue to be
kept confidential and subject of the terms of this Agreement.

 

f)In
the event receiving Party is legally compelled to disclose Confidential Information belonging to disclosing Party, the receiving
Party shall promptly notify disclosing Party of each such requirement so that disclosing Party may seek a protective order or other
appropriate remedy and/or waive compliance with the provisions of this Agreement. In any such event, receiving Party will only
disclose such Confidential Information that s/he/it is advised by counsel to disclose and legally required to be disclosed and
shall exercise reasonable efforts to obtain assurance that confidential treatment will be accorded to such Confidential Information. 

 

g)The
receiving Party’s access to Confidential Information shall automatically terminate at the termination or expiration of the
relationship between the Parties with respect to the subject matter of this Agreement. Notwithstanding the foregoing, disclosing
Party may immediately terminate access to its Confidential Information at any time. 

 

h)Neither
of the Parties to this Agreement shall make any announcement of the proposed transaction contemplated by this Agreement, without
the prior written approval of the other, which approval will not be unreasonably withheld or delayed.   The foregoing
shall not restrict in any respect the Party’s ability to communicate information concerning this Agreement, and the transactions
contemplated hereby, to their respective affiliates’, officers, directors, employees and professional advisers; and, (to
the extent relevant), to third parties whose consent is required in connection with the transaction contemplated by this Agreement. 

 

 

2)NON-CIRCUMVENTION.
  

 

a)The
Parties understand that in the performance of this Agreement they may each reveal to each other, contacts and relationships which
are not otherwise known to the general public or to whom the general public may otherwise not have access. 

 

b)The
Parties will not in any manner solicit, nor do business in any manner with individuals, entities, related parties or their affiliates
(“Source(es)”), which were made available to them through this Agreement by the other Party, without the express permission
of the party who made available the Source; 

Business Agreement

Page 6 of 13

 

c)Source
shall include, without limitation, any contact, contract or transaction with all persons, companies (e.g., limited liability companies,
etc.), firms, partnerships (e.g., general partnerships, limited liability partnerships, etc.), corporations (e.g., domestic, foreign,
international), co-ventures, joint ventures, trusts or any other entity with which they or any associate, agent, employee, or representative
are or may be in any way associated or concerned, no matter the country of origin or origination of the association. 

 

d)A
Party will not attempt either directly or indirectly, for the purposes of circumventing the other Party, to make any contact with
any individual or entity, including without limitation relationships, customers or clients, whose identity is made known to one
Party solely in connection with their relationship with the other Party, as contemplated by this Agreement, without the prior written
approval of such other Party. The identity of such individuals and entities shall be deemed proprietary and valuable to the Party
in whose knowledge, such identity currently resides. 

 

e)The
Parties will maintain complete confidentiality regarding each other’s Sources and will disclose such Sources only to third
parties only pursuant to the express written permission of the Party who made available the Source; 

 

f)The
Parties will not disclose names, addresses, e-mail address, telephone and tele-fax or telex numbers to any Sources, to third parties
and the Parties each recognize such Sources as the exclusive property of the providing Party and they will not enter into any direct
negotiations or transactions with such Sources revealed by the other Party; 

 

g)The
Parties further undertake not to enter into business transaction with banks, iHealthcare’s sources of funds or other bodies,
the names of which have been provided by one of the Parties to this agreement, unless written permission has been obtained from
the other Party to do so.  

 

h)The
Parties also undertake not to make use of a third party to circumvent this clause. 

 

3)COVENANT
NOT TO COMPETE 

 

a)In
accordance with this Agreement, the Parties will gain knowledge of certain proprietary information belonging to the other Party
and valuable confidential business or professional information. The Parties may also acquire substantial relationships with specific
prospective or existing customers or clients and gain customer or client goodwill associated with the Parties’ ongoing business
or professional practice. The Parties may additionally be provided with extraordinary or specialized training, specific to the
Parties’ field of business and specific business. In light of the above, the Parties acknowledges and agrees that the they
each are entitled to a Covenant Not To Compete and such restraint is reasonably necessary to protect the legitimate business interest
or interests of the Parties, to the extent that there is an Ongoing Entity. 

Business Agreement

Page 7 of 13

b)Accordingly,
during the Parties’ relationship with each other and for a period of 10 years from the date of this Agreement, for any reason,
the Parties shall not, directly or indirectly, through another person or entity, compete with the each other anywhere where the
Ongoing Entity does business or owns an interest in or, as principal, agent, contractor, consultant, or employee or otherwise,
engages in activities for or renders services to any firm or business that competes with the Ongoing Entity, “Compete”
being defined as conducting business in the marketplace, contracting for hospital management services and all related marketing
models and business models. The territory shall be deemed to initially be the United States of America and such other locations
as the Ongoing Entity may be doing business at any time and also those States in which Ongoing Entity has reasonably advanced toward
doing business.  

 

c)“Compete”
shall additionally include without limitation, soliciting, providing services to, or otherwise engaging in a business transaction
with customers or clients of the Ongoing Entity or any affiliate of the Ongoing Entity, or directly or indirectly soliciting for
employment any of the Ongoing Entity’s employees, or the employees of any of the Ongoing Entity’s affiliates. 

 

4)INDEMNIFICATION
AND MUTUAL HOLD HARMLESS 

 

(a) Perez shall indemnify, defend and hold harmless iHealthcare
and its affiliates, their respective shareholders, officers, directors, employees, and agents, against and in respect of any and
all losses, claims, damages, causes of action, actions, obligations, liabilities, deficiencies, suits, proceedings, actual out-of-pocket
obligations and expenses (including cost of investigation, interest, penalties and reasonable attorneys' fees) (collectively, "Losses")
arising out of or due to the operation of the Business or relating to events prior to closing by iHealthcare, its affiliates, agents,
servants and/or employees after Closing  under the provisions of this Agreement. The obligations set forth in this Section
7(a) shall survive for a period of ten (10 years following the Expiration Date.

 

(b) iHealthcare shall indemnify, defend and hold harmless
Perez and its affiliates, their respective shareholders, officers, directors, employees, and agents, against and in respect of
any and all Losses arising out of or due to gross negligence of the Manager, its affiliates, agents, servants and/or employees
prior to and during the commencement of the term of this Agreement. The obligations set forth in this Section 7(b) shall survive
for a period of ten (10) years following the Expiration Date.

 

(c) If a party entitled to indemnification (the "Indemnitee")
receives notice of any claim or the commencement of any action or proceeding with respect to which a party is obligated to provide
indemnification (the "Indemnifying Party") pursuant to subsections (a) and (b) of this Section, the Indemnitee shall
promptly give the Indemnifying Party notice thereof (Indemnification Notice"). Such Indemnification Notice shall be a condition
precedent to any liability of the Indemnifying Party under the provisions for indemnification contained in this Agreement. Except
as provided below, the Indemnifying Party may compromise, settle or defend, at such Indemnifying Party's own expense and by such
Indemnifying Party's own counsel, any such matter involving the asserted liability of the Indemnitee. In any event, the Indemnitee,
the Indemnifying Party and the

Business Agreement

Page 8 of 13

Indemnifying Party's counsel shall cooperate in the compromise
of, or defense against, any such asserted liability. If the Indemnifying Party provides the Indemnitee a defense to a third party
claim at the Indemnifying Party's cost with a qualified attorney, Indemnitee may participate and/or monitor the defense with an
attorney of the Indemnitee's selection (at the Indemnitee's own expense). Provided that the Indemnifying Party pays for the full
cost of the settlement of any claim, the Indemnifying Party may settle any claim without the consent of the Indemnitee. If the
Indemnifying Party chooses to defend any claim, the Indemnitee shall make available to the Indemnifying Party any books, records
or other documents within its control that are necessary or appropriate for such defense.

 

8. LIMITATION OF LIABILITY

 

NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY SPECIAL,
CONSEQUENTIAL, INCIDENTAL, PUNITIVE, OR INDIRECT DAMAGES ARISING FROM OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF
ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. NOTWITHSTANDING THE FOREGOING, NOTHING IN THIS PARAGRAPH IS INTENDED TO LIMIT OR
RESTRICT THE INDEMNIFICATION RIGHTS OR OBLIGATIONS OF ANY PARTY UNDER SECTION 7, OR DAMAGES AVAILABLE FOR BREACHES OF THE OBLIGATIONS
SET FORTH IN SECTION 7.

 

a)Upon
request of any Party to this Agreement, the requested Party(ies) shall take such further actions, and shall cause its (their) personnel,
agents, and employees to take such further actions, including execution and delivery of documents, that may reasonably be deemed
necessary or desirable to accomplish or evidence more further the objectives and intent of this Agreement.   

 

b)This
Agreement contains the complete understanding between the Parties and shall as of the date hereof, supersede all other agreements,
whether they are written or oral, between the Parties concerning the particular subject matter.  Paragraphs 2 through 11 constitute
a binding contract and will continue in full force and effect surviving the termination of this Agreement.  Paragraph 1 is
a statement of interest and intent to do business, but as set forth above, Paragraph 1 shall become binding to the extent that
the Parties complete Due Diligence (as defined below) and iHealthcare elects to proceed, or where iHealthcare provides any capital
to Perez, without a more formal writing, the substantive terms herein shall be conclusive as to the agreement of the Parties.  Further,
to the extent that additional substantive terms are in issue, the course of conduct of the Parties shall be controlling as to such
terms. 

 

c)No
waiver or modification of this Agreement or any covenant, condition or limitation herein contained shall be valid and no evidence
of waiver or modification shall be offered or received in evidence in any proceeding, arbitration or litigation between the Parties
hereto arising out of or affecting this Agreement or the rights or obligations of the Parties hereunder, unless such waiver or
modification is in writing duly signed by all Parties, or in an email exchange where both Parties have commented. 

Business Agreement

Page 9 of 13

d)All
agreements and covenants contained herein are severable, and in the event that any of them shall be held to be invalid by any competent
court, this Agreement shall be interpreted as if such invalid agreement or covenant is not contained herein. 

 

e)The
failure of any Party to insist in any one or more instances upon performance of any terms or conditions of this Agreement shall
not be construed as a waiver of future performance of any such term, covenant, or condition, but the obligations of any Party with
respect thereto shall continue in full force and effect. 

 

f)Neither
this Agreement nor any interest herein may be assigned in whole or in part by any Party hereto without the prior written consent
of all other Parties. 

 

g)The
terms and existence of this Agreement are confidential, and neither the contents nor its details of the Agreement may be shown
or disclosed by either Party, except to those individuals with who have a need to know as a result of being involved in or related
to this Agreement. 

 

h)In
addition to any remedies under the applicable law, the Parties recognize that any breach or violation of any provision of this
Agreement may cause irreparable harm to the other Party, which money damages may not necessarily remedy. Therefore, upon any actual
or impending violation of any provision of this Agreement, either Party may obtain from any court of competent jurisdiction a preliminary,
temporary or permanent injunction, restraining or enjoining such violation by the other Party or any entity or person acting in
concert with that Party. 

 

i)This
Agreement shall be governed by and interpreted in accordance with the laws of the State of Florida. IF A DISPUTE ARISES, THE PARTIES
WILL: (a) RESOLVE ALL DISPUTES BY BINDING ARBITRATION HELD IN MIAMI-DADE COUNTY, FLORIDA BEFORE A SINGLE ARBITRATOR FROM JUDICIAL
ARBITRATION AND MEDIATION SERVICES, INC. (“JAMS”); AND (b) WAIVE ANY RIGHT TO CIVIL TRIAL BY JUDGE OR JURY.  Notwithstanding
the foregoing, all claims alleging violation of restrictive covenants, mishandling of Confidential Information, or transgression
of intellectual property rights, shall be subject to the exclusive jurisdiction, in Miami, Florida, of either the Florida state
courts or the US District Court.  Before accepting appointment, the arbitrator shall agree: (a) that the arbitrator’s
award shall be made within nine (9) months of the filing of a notice of intention (or demand) to arbitrate  (but it may be
extended by written agreement of the parties); (b) to base any decision or award on governing law; (c) to not award punitive or
other damages that are not measured by the prevailing party’s actual damages, except as may be required by statute; and (d)
to issue an award in writing within ten (10) days of concluding the presentation of evidence and briefs.  Judgment may be
entered in any court having jurisdiction thereof.  The prevailing party shall be entitled to recover from the other party
its costs and expenses, including reasonable attorney’s fees. 

 

j)Authority:
Perez have full power and authority and are legally authorized to execute and bind the hospitals to new management contracts for
the benefit of iHealthcare Management  

Business Agreement

Page 10 of 13

Company.

 

 

a.The
Parties further agree: 

 

1.To
the extent that they are not in conflict with this document, that the use of electronic messages shall create valid and enforceable
rights and obligations between them; and 

 

2.That
to the extent permitted under the applicable law, electronic messages shall be admissible as evidence, provided that such electronic
messages are sent to addresses and in formats, if any, designated either expressly or implicitly by the addresses; and  

 

3.Not
to challenge the validity of any communication or agreement between them solely on the ground of the use of electronic means, whether
or not such use was reviewed by any natural person. 

 

1.This
Agreement may be executed in separate counterparts all of which shall be deemed to be one (1) agreement. 

 

 

 

SIGNATURE PAGE TO FOLLOW

Business Agreement

Page 11 of 13

IN WITNESS WHEREOF, the Parties have caused this Agreement
to be Accepted and Agreed to as of January 7, 2019.

 

 

 

JORGE A. PEREZiHealthcare Management Company  

 

 

By: /s/ Jorge A. Perez By:  /s/ Noel
Mijares   

Jorge A. Perez                         
Noel Mijares, Chief Executive Officer 

Business Agreement

Page 12 of 13

 

BUSINESS DEVELOPMENT AGREEMENT

Regional General Hospital

 

This document (“Agreement”)
reflects the agreement of iHealthcare Management Company, a Florida Corporation with an address of 3901 NW 28th Street,
2nd Floor, Miami, Florida 33142, (“iHealthcare”) and Jorge A. Perez with an address of 13595 SW 134 Avenue,
Suite 209, Miami, Florida, 33186 , (“Perez”) (hereinafter, collectively iHealthcare and Perez are also known as the
“Parties,” or individually as a “Party”) to engage in business on the terms set forth below, as well as
such other terms and conditions as the Parties may agree.  The Parties may reduce the terms listed below to a more complete
written agreement, but they are not required to do so.

 

WHEREAS, iHealthcare is in the hospital management
business through its wholly owned subsidiary iHealthcare Management Company and desires to expand its hospital management business; 

WHEREAS, Perez has demonstrated a track record
of developing and securing hospital management contracts; 

WHEREAS, the Parties desire to use their respective
assets for the common goal of assisting the rural healthcare landscape, driving healthcare insurance costs down, providing innovative
products and tools, and growing a small footprint of Hospitals and Service Offerings into a major sustainable business that will
serve communities throughout the United States; 

WHEREAS, the Parties consider their ongoing
relationship and potential business relationship to be independently valuable;  

NOW, THEREFORE, for and in consideration of the ongoing
and potential relationship between iHealthcare and Perez, and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, iHealthcare and Perez, intending to be legally bound, do hereby agree as follows and acknowledge
the above recitals as true and incorporated herein, and: 

 

1)BUSINESS
DEVELOPMENT ENGAGEMENT:  

 

a)iHealthcare
hereby engages Perez to deliver certain valid, binding, exclusive and executed hospital management contracts for new business for
and on behalf of iHealthcare Management Company;  

Business Agreement

Page 1 of 13

b)Perez
shall utilize the iHealthcare Management Company contract template [attached]; 

c)Perez
shall obtain any required consents, authorizations and binding approvals necessary to deliver an executed binding ten-year contracts
for hospital management services to iHealthcare Management Company;  

d)Perez
will ensure iHealthcare is the exclusive provider of management services under these new agreements; 

e)Perez
will ensure that no liabilities of any kind which nay have incurred prior to the new contract inception date will transfer, assign
or inure to iHealthcare Management Company;  

f)The
target inception date will be January 7, 2019 and limited only to the following target hospital: Regional Healthcare Partners LLC
dba Regional General Hospital;  

 

2)TERMS.
 The Parties herby agree as follows:  

 

a)The
parties acknowledge that under this Business Development Agreement, the Parties agree to mutually work together to grow the business
model and create new revenue lines that are currently not operational.  

b)The
contracts, once executed, must have a 10-year non-cancelable term with renewals. 

 

3)CONSIDERATION:
With this in mind, the consideration for this business development effort will be a Success Fee structured as a Promissory Note
and Stock as follows:  

 

a)Success
Fee: $780,000.00 

1.The
Success Fee will be earned upon delivery of a legally binding and executed Management and Administrative Services Agreement.  
The Success Fee is based on a negotiated value.   

 

b)Terms
in General:  

1.iHealthcare
shall issue a Promissory Note for 100% of the agreed value under this Business Development Agreement.  

2.Promissory
Note will have a 10 year term and 4% simple annual interest on the unpaid balance.  

3.Payment:
Promissory Note may be prepaid without penalty, in full or in part, in cash or common stock at the option of iHealthcare. 

4.Default:
In the event of a default, iHealthcare shall be granted 45 days to cure, as stipulated in the Management and Administrative Services
Agreement. 

5.Security:
In the event of failure to cure the default after the 45-day period and remedy specified in the
Management and Administrative Services Agreement, the management agreement shall be surrendered to the Lender as security. 

6.Adjustments:
In the event that any of the named hospitals closes or is placed in receivership, files for bankruptcy, becomes insolvent or is
assigned to creditors, the portion of the Success Fee allocated to that specific hospital only shall be adjusted accordingly and
the associated portion of the Promissory Note shall be adjusted to reflect the change in event and the balance due shall be reduced
to reflect that portion for the remaining term of the note.  

7.Offsets:
This Agreement is based on the premise that the Hospital Management and Administrative Services Agreement will be in effect for
10 full years which enables  

Business Agreement

Page 2 of 13

iHealthcare to fund the payments for the Promissory
Note during this term. Therefore, there may be a pro rata offset to the balance of the Promissory Note if one or more of the following
occur during the ten-year term:

a)Any
early cancellation or termination of the contract that is not as a result of breach of contract by iHealthcare. 

b)Failure
to enforce the tagalong provision of the contract. 

c)A
Hospital ownership action to close the hospital. 

d)Loss
or suspension of Hospital License or Medicare Provider status relating to events occurring prior to closing. 

e)In
the event that the hospital closes or is placed in receivership, files for bankruptcy, becomes insolvent or is assigned to creditors,
the portion of the Success Fee listed in the Business Development Agreement shall be adjusted accordingly and the remaining portion
of this Promissory Note shall be adjusted to reflect the change in event and the balance due shall be reduced to reflect that portion
for the remaining term of the note. 

f)Any
Offset is subject to arbitration and other remedies as specified in the Hospital Management and Administrative Services Agreement.
  

g)Liabilities
incurred prior to closing.  

 

c)Terms
of Preferred B Stock from iHealthcare, Inc:  

 

1.Success
Event: Final delivery of a fully executed, legally binding Management and Administrative Services Agreement for Regional Healthcare
Partners LLC dba Regional General Hospital. 

2.Preferred
Series B Shares: A total of 45,460 Preferred Series B Shares par value $0.0001 per share will be allocated to the Perez -Tio
Family Trust, as part of the Success Fee of this Agreement as earned per contract: 

a)Regional
Healthcare Partners LLC dba Regional General Hospital 45,460 shares 

3.Conversion
Value: One share of Preferred B for one share of Common Stock - Converted at the option of the Holder.  

4.Restrictions:
Shares will be restricted for 6 months from issuance per SEC regulations. 

5.COC:
Accelerated Conversion and call back on then existing terms at Change of Control. 

6.Call
Option: iHealthcare may call or force conversion all or part of the stock in the event of a recapitalization or liquidation
event or public offering.  

7.Voting:
Preferred B Shares are voting as one vote per share. 

8.Reserves:
iHealthcare Inc. shall reserve sufficient shares of Preferred B and Common stock to meet the obligations of this agreement. 

9.Interest:
No interest is paid or due on equity offers. 

10.Conditions:
The specific terms of Preferred B Shares are set and fixed by iHealthcare’s Articles of Incorporation. 

 

 

 

 

d)Terms
of Preferred C Stock from iHealthcare Inc:     

Business Agreement

Page 3 of 13

 

1.Success
Event: Final delivery of a fully executed, legally binding Management and Administrative Services Agreement for Regional Healthcare
Partners LLC dba Regional General Hospital.  

2.Preferred
Series C Shares: A total of 45,460 Preferred Series C Shares par value $0.0001 per share will be allocated to the Perez -Tio
Family Trust, as part of the Success Fee of this Agreement as earned per contract: 

a)Regional
Healthcare Partners LLC dba Regional General Hospital: 45,460 shares. 

3.Terms:
Terms will be governed by the Certificate of Designation for Preferred C Shares filed with the State of Delaware along with Board
Resolution. 

These shares shall be earned as follows  

4.Convertible
Note: The 45,460 Preferred Shares C will be issued as a Convertible Note to the Perez – Tio Family Trust. 

5.Conversion:
The Conversion value is one share of Preferred Stock to one share of Common Stock 

6.Value
Assurance Guarantee:  When converted from Preferred Shares to Common Stock, iHealthcare guarantees a minimum value, only
on the date of conversion, of $1.00 per share converted. If the value of the Common Stock trading on that day is below $1.00 per
share, the company will issue sufficient additional Common Stock share’s so that the total value of the redeemed converted
Preferred Stock redeemed to Common Stock equals a minimum of $1.00 per share based on the conversion date’s closing per share
value of Common Stock. If the value is in excess of $1.00 per share on the date of conversion, the share conversion remains 1:1
and the Holder shall retain the upside value, if any. Common stock must be trading on a public exchange to qualify. 

7.Restricted
Share Tranches and Vesting: When each restricted share tranche reaches maturity in the Convertible Note on the following schedule
of performance, the note will covert to Preferred Shares as listed, at the option of the Holder.  

a)45,460
shares vested upon closing.   

8.Restricted
Share Conversion Schedule: Vested Preferred shares may convert and then shall be exercisable for conversion to Common Stock,
all or in part or none, at the option of the Holder only after the closing of the new management contracts, the following schedule:
 

a)45,460
shares – 12 months from date of closing. 

1.COC:
Accelerated Conversion and call back on then existing terms at Change of Control. 

2.Call
Option: iHealthcare may call or force conversion all or part of the stock in the event of a recapitalization or liquidation
event or public offering.  

3.Voting:
Preferred C Shares are non-voting until converted to Common Stock.  

4.Reserves:
iHealthcare Inc. shall reserve sufficient shares of Preferred C and Common stock to meet the obligations of this agreement. 

5.Interest:
No interest is paid or due on equity offers. 

 

 

1)NONDISCLOSURE
AND NONUSE OF CONFIDENTIAL INFORMATION.   

Business Agreement

Page 4 of 13

a)The
Parties acknowledge that they each have, may obtain or may develop certain Confidential Information (as defined below) in the ordinary
course of their business and that the Parties may learn of, or have access to, each other’s Confidential Information during
the course of their business relationship with each other. 

 

b)For
the purposes of this Agreement, the term “Confidential Information” shall mean any and all confidential and/or proprietary
knowledge, data, information or trade secrets used, obtained, or developed by or for a Party that is treated as confidential by
that Party, or is of a nature that should reasonably be understood by the receiving Party to be confidential, and is not and otherwise
would not be regularly and routinely available to the general public.  The term “Confidential Information,” includes,
without limitation, information and data, whether in written, oral, graphic or machine-readable form, but shall not include that
which is (i) publicly available by other than unauthorized means, (ii) disclosed to others by the disclosing Party or other proper
Party without restriction, (iii) rightfully received from a third party without restriction, (iv) discoverable by common observation,
through publicly or commercially available sources, or by inspection or analysis of products in the market place, or (v) general
skill and knowledge. 

 

c)The
receiving Party hereby agrees to comply with any and all of the disclosing Party’s commercially reasonable policies and procedures
for the protection of Confidential Information and, except as required by law or by the nature of receiving Party’s duties
for the disclosing Party or with the prior written approval of an authorized officer of the disclosing Party, receiving Party will
not, during its business relationship with disclosing Party or at any time thereafter, use or disclose, directly or indirectly
in any manner, any Confidential Information of the disclosing Party, including the fact that Confidential Information has been
made available to the receiving Party for any purpose other than in furtherance of the business relationship with disclosing Party.
The provisions of this Agreement regarding disclosure and use of Confidential Information shall survive the termination or expiration
of this Agreement and shall be effective forever.  

 

d)The
receiving Party hereby agrees that any Confidential Information is and shall remain the sole and exclusive property of the disclosing
Party for use in the disclosing Party’s business and shall be used solely in connection with furtherance of the business
relationship with disclosing Party and shall not be used by receiving Party, directly or indirectly, in any other manner whatsoever.
 Under no circumstances whatsoever shall receiving Party have any proprietary or other legal right to the disclosing Party’s
Confidential Information during, or subsequent to the termination or cessation of, the business relationship of the Parties. 

 

e)The
receiving Party hereby agrees not to disclose, copy, or remove from the premises of the disclosing Party any documents, records,
tapes or other media or format that contain or may contain Confidential Information, except as required by the nature of receiving
Party’s duties for the disclosing Party or as otherwise approved in writing by an authorized officer of the disclosing Party.
 Upon termination or cessation of the  

Business Agreement

Page 5 of 13

business relationship of the Parties, regardless
of the reason for such termination or cessation, receiving Party hereby agrees to return immediately to the disclosing Party, or
destroy at the disclosing Party’s discretion, all originals and copies of documents, records, tapes, or any other media or
format that contain or may contain Confidential Information. Furthermore, all Confidential Information belonging to disclosing
Party will be and remain solely the property of disclosing Party.  Any such return or destruction, as applicable, of Confidential
Information shall be certified in writing by receiving Party to disclosing Party within three (3) days of the return or destruction.
Any Confidential Information that is not returned or destroyed, including any oral Confidential Information, will continue to be
kept confidential and subject of the terms of this Agreement.

 

f)In
the event receiving Party is legally compelled to disclose Confidential Information belonging to disclosing Party, the receiving
Party shall promptly notify disclosing Party of each such requirement so that disclosing Party may seek a protective order or other
appropriate remedy and/or waive compliance with the provisions of this Agreement. In any such event, receiving Party will only
disclose such Confidential Information that s/he/it is advised by counsel to disclose and legally required to be disclosed and
shall exercise reasonable efforts to obtain assurance that confidential treatment will be accorded to such Confidential Information. 

 

g)The
receiving Party’s access to Confidential Information shall automatically terminate at the termination or expiration of the
relationship between the Parties with respect to the subject matter of this Agreement. Notwithstanding the foregoing, disclosing
Party may immediately terminate access to its Confidential Information at any time. 

 

h)Neither
of the Parties to this Agreement shall make any announcement of the proposed transaction contemplated by this Agreement, without
the prior written approval of the other, which approval will not be unreasonably withheld or delayed.   The foregoing
shall not restrict in any respect the Party’s ability to communicate information concerning this Agreement, and the transactions
contemplated hereby, to their respective affiliates’, officers, directors, employees and professional advisers; and, (to
the extent relevant), to third parties whose consent is required in connection with the transaction contemplated by this Agreement. 

 

 

2)NON-CIRCUMVENTION.
  

 

a)The
Parties understand that in the performance of this Agreement they may each reveal to each other, contacts and relationships which
are not otherwise known to the general public or to whom the general public may otherwise not have access. 

 

b)The
Parties will not in any manner solicit, nor do business in any manner with individuals, entities, related parties or their affiliates
(“Source(es)”), which were made available to them through this Agreement by the other Party, without the express permission
of the party who made available the Source; 

Business Agreement

Page 6 of 13

 

c)Source
shall include, without limitation, any contact, contract or transaction with all persons, companies (e.g., limited liability companies,
etc.), firms, partnerships (e.g., general partnerships, limited liability partnerships, etc.), corporations (e.g., domestic, foreign,
international), co-ventures, joint ventures, trusts or any other entity with which they or any associate, agent, employee, or representative
are or may be in any way associated or concerned, no matter the country of origin or origination of the association. 

 

d)A
Party will not attempt either directly or indirectly, for the purposes of circumventing the other Party, to make any contact with
any individual or entity, including without limitation relationships, customers or clients, whose identity is made known to one
Party solely in connection with their relationship with the other Party, as contemplated by this Agreement, without the prior written
approval of such other Party. The identity of such individuals and entities shall be deemed proprietary and valuable to the Party
in whose knowledge, such identity currently resides. 

 

e)The
Parties will maintain complete confidentiality regarding each other’s Sources and will disclose such Sources only to third
parties only pursuant to the express written permission of the Party who made available the Source; 

 

f)The
Parties will not disclose names, addresses, e-mail address, telephone and tele-fax or telex numbers to any Sources, to third parties
and the Parties each recognize such Sources as the exclusive property of the providing Party and they will not enter into any direct
negotiations or transactions with such Sources revealed by the other Party; 

 

g)The
Parties further undertake not to enter into business transaction with banks, iHealthcare’s sources of funds or other bodies,
the names of which have been provided by one of the Parties to this agreement, unless written permission has been obtained from
the other Party to do so.  

 

h)The
Parties also undertake not to make use of a third party to circumvent this clause. 

 

3)COVENANT
NOT TO COMPETE 

 

a)In
accordance with this Agreement, the Parties will gain knowledge of certain proprietary information belonging to the other Party
and valuable confidential business or professional information. The Parties may also acquire substantial relationships with specific
prospective or existing customers or clients and gain customer or client goodwill associated with the Parties’ ongoing business
or professional practice. The Parties may additionally be provided with extraordinary or specialized training, specific to the
Parties’ field of business and specific business. In light of the above, the Parties acknowledges and agrees that the they
each are entitled to a Covenant Not To Compete and such restraint is reasonably necessary to protect the legitimate business interest
or interests of the Parties, to the extent that there is an Ongoing Entity. 

Business Agreement

Page 7 of 13

b)Accordingly,
during the Parties’ relationship with each other and for a period of 10 years from the date of this Agreement, for any reason,
the Parties shall not, directly or indirectly, through another person or entity, compete with the each other anywhere where the
Ongoing Entity does business or owns an interest in or, as principal, agent, contractor, consultant, or employee or otherwise,
engages in activities for or renders services to any firm or business that competes with the Ongoing Entity, “Compete”
being defined as conducting business in the marketplace, contracting for hospital management services and all related marketing
models and business models. The territory shall be deemed to initially be the United States of America and such other locations
as the Ongoing Entity may be doing business at any time and also those States in which Ongoing Entity has reasonably advanced toward
doing business.  

 

c)“Compete”
shall additionally include without limitation, soliciting, providing services to, or otherwise engaging in a business transaction
with customers or clients of the Ongoing Entity or any affiliate of the Ongoing Entity, or directly or indirectly soliciting for
employment any of the Ongoing Entity’s employees, or the employees of any of the Ongoing Entity’s affiliates. 

 

4)INDEMNIFICATION
AND MUTUAL HOLD HARMLESS 

 

(a) Perez shall indemnify, defend and hold harmless iHealthcare
and its affiliates, their respective shareholders, officers, directors, employees, and agents, against and in respect of any and
all losses, claims, damages, causes of action, actions, obligations, liabilities, deficiencies, suits, proceedings, actual out-of-pocket
obligations and expenses (including cost of investigation, interest, penalties and reasonable attorneys' fees) (collectively, "Losses")
arising out of or due to the operation of the Business or relating to events prior to closing by iHealthcare, its affiliates, agents,
servants and/or employees after Closing  under the provisions of this Agreement. The obligations set forth in this Section
7(a) shall survive for a period of ten (10 years following the Expiration Date.

 

(b) iHealthcare shall indemnify, defend and hold harmless
Perez and its affiliates, their respective shareholders, officers, directors, employees, and agents, against and in respect of
any and all Losses arising out of or due to gross negligence of the Manager, its affiliates, agents, servants and/or employees
prior to and during the commencement of the term of this Agreement. The obligations set forth in this Section 7(b) shall survive
for a period of ten (10) years following the Expiration Date.

 

(c) If a party entitled to indemnification (the "Indemnitee")
receives notice of any claim or the commencement of any action or proceeding with respect to which a party is obligated to provide
indemnification (the "Indemnifying Party") pursuant to subsections (a) and (b) of this Section, the Indemnitee shall
promptly give the Indemnifying Party notice thereof (Indemnification Notice"). Such Indemnification Notice shall be a condition
precedent to any liability of the Indemnifying Party under the provisions for indemnification contained in this Agreement. Except
as provided below, the Indemnifying Party may compromise, settle or defend, at such Indemnifying Party's own expense and by such
Indemnifying Party's own counsel, any such matter involving the asserted liability of the Indemnitee. In any event, the Indemnitee,
the Indemnifying Party and the

Business Agreement

Page 8 of 13

Indemnifying Party's counsel shall cooperate in the compromise
of, or defense against, any such asserted liability. If the Indemnifying Party provides the Indemnitee a defense to a third party
claim at the Indemnifying Party's cost with a qualified attorney, Indemnitee may participate and/or monitor the defense with an
attorney of the Indemnitee's selection (at the Indemnitee's own expense). Provided that the Indemnifying Party pays for the full
cost of the settlement of any claim, the Indemnifying Party may settle any claim without the consent of the Indemnitee. If the
Indemnifying Party chooses to defend any claim, the Indemnitee shall make available to the Indemnifying Party any books, records
or other documents within its control that are necessary or appropriate for such defense.

 

8. LIMITATION OF LIABILITY

 

NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY SPECIAL,
CONSEQUENTIAL, INCIDENTAL, PUNITIVE, OR INDIRECT DAMAGES ARISING FROM OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF
ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. NOTWITHSTANDING THE FOREGOING, NOTHING IN THIS PARAGRAPH IS INTENDED TO LIMIT OR
RESTRICT THE INDEMNIFICATION RIGHTS OR OBLIGATIONS OF ANY PARTY UNDER SECTION 7, OR DAMAGES AVAILABLE FOR BREACHES OF THE OBLIGATIONS
SET FORTH IN SECTION 7.

 

a)Upon
request of any Party to this Agreement, the requested Party(ies) shall take such further actions, and shall cause its (their) personnel,
agents, and employees to take such further actions, including execution and delivery of documents, that may reasonably be deemed
necessary or desirable to accomplish or evidence more further the objectives and intent of this Agreement.   

 

b)This
Agreement contains the complete understanding between the Parties and shall as of the date hereof, supersede all other agreements,
whether they are written or oral, between the Parties concerning the particular subject matter.  Paragraphs 2 through 11 constitute
a binding contract and will continue in full force and effect surviving the termination of this Agreement.  Paragraph 1 is
a statement of interest and intent to do business, but as set forth above, Paragraph 1 shall become binding to the extent that
the Parties complete Due Diligence (as defined below) and iHealthcare elects to proceed, or where iHealthcare provides any capital
to Perez, without a more formal writing, the substantive terms herein shall be conclusive as to the agreement of the Parties.  Further,
to the extent that additional substantive terms are in issue, the course of conduct of the Parties shall be controlling as to such
terms. 

 

c)No
waiver or modification of this Agreement or any covenant, condition or limitation herein contained shall be valid and no evidence
of waiver or modification shall be offered or received in evidence in any proceeding, arbitration or litigation between the Parties
hereto arising out of or affecting this Agreement or the rights or obligations of the Parties hereunder, unless such waiver or
modification is in writing duly signed by all Parties, or in an email exchange where both Parties have commented. 

Business Agreement

Page 9 of 13

d)All
agreements and covenants contained herein are severable, and in the event that any of them shall be held to be invalid by any competent
court, this Agreement shall be interpreted as if such invalid agreement or covenant is not contained herein. 

 

e)The
failure of any Party to insist in any one or more instances upon performance of any terms or conditions of this Agreement shall
not be construed as a waiver of future performance of any such term, covenant, or condition, but the obligations of any Party with
respect thereto shall continue in full force and effect. 

 

f)Neither
this Agreement nor any interest herein may be assigned in whole or in part by any Party hereto without the prior written consent
of all other Parties. 

 

g)The
terms and existence of this Agreement are confidential, and neither the contents nor its details of the Agreement may be shown
or disclosed by either Party, except to those individuals with who have a need to know as a result of being involved in or related
to this Agreement. 

 

h)In
addition to any remedies under the applicable law, the Parties recognize that any breach or violation of any provision of this
Agreement may cause irreparable harm to the other Party, which money damages may not necessarily remedy. Therefore, upon any actual
or impending violation of any provision of this Agreement, either Party may obtain from any court of competent jurisdiction a preliminary,
temporary or permanent injunction, restraining or enjoining such violation by the other Party or any entity or person acting in
concert with that Party. 

 

i)This
Agreement shall be governed by and interpreted in accordance with the laws of the State of Florida. IF A DISPUTE ARISES, THE PARTIES
WILL: (a) RESOLVE ALL DISPUTES BY BINDING ARBITRATION HELD IN MIAMI-DADE COUNTY, FLORIDA BEFORE A SINGLE ARBITRATOR FROM JUDICIAL
ARBITRATION AND MEDIATION SERVICES, INC. (“JAMS”); AND (b) WAIVE ANY RIGHT TO CIVIL TRIAL BY JUDGE OR JURY.  Notwithstanding
the foregoing, all claims alleging violation of restrictive covenants, mishandling of Confidential Information, or transgression
of intellectual property rights, shall be subject to the exclusive jurisdiction, in Miami, Florida, of either the Florida state
courts or the US District Court.  Before accepting appointment, the arbitrator shall agree: (a) that the arbitrator’s
award shall be made within nine (9) months of the filing of a notice of intention (or demand) to arbitrate  (but it may be
extended by written agreement of the parties); (b) to base any decision or award on governing law; (c) to not award punitive or
other damages that are not measured by the prevailing party’s actual damages, except as may be required by statute; and (d)
to issue an award in writing within ten (10) days of concluding the presentation of evidence and briefs.  Judgment may be
entered in any court having jurisdiction thereof.  The prevailing party shall be entitled to recover from the other party
its costs and expenses, including reasonable attorney’s fees. 

 

j)Authority:
Perez have full power and authority and are legally authorized to execute and bind the hospitals to new management contracts for
the benefit of iHealthcare Management  

Business Agreement

Page 10 of 13

Company.

 

 

a.The
Parties further agree: 

 

1.To
the extent that they are not in conflict with this document, that the use of electronic messages shall create valid and enforceable
rights and obligations between them; and 

 

2.That
to the extent permitted under the applicable law, electronic messages shall be admissible as evidence, provided that such electronic
messages are sent to addresses and in formats, if any, designated either expressly or implicitly by the addresses; and  

 

3.Not
to challenge the validity of any communication or agreement between them solely on the ground of the use of electronic means, whether
or not such use was reviewed by any natural person. 

 

1.This
Agreement may be executed in separate counterparts all of which shall be deemed to be one (1) agreement. 

 

 

 

SIGNATURE PAGE TO FOLLOW

Business Agreement

Page 11 of 13

IN WITNESS WHEREOF, the Parties have caused this Agreement
to be Accepted and Agreed to as of January 7, 2019.

 

 

 

JORGE A. PEREZ iHealthcare Management Company 

 

 

 

By: /s/ Jorge A. Perez By:  /s/ Noel
Mijares   

Jorge A. Perez                         
Noel Mijares, Chief Executive Officer 

Business Agreement

Page 12 of 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]